Evidence That
Speaks for Itself

This U.S. Government Accountability Office report examines the challenges faced by Americans experiencing symptoms associated with Havana Syndrome, also known as Anomalous Health Incidents (AHIs). It outlines the global spread of reported cases, the severity of neurological symptoms, and the difficulties survivors face when seeking medical evaluation and treatment. The report also details gaps in support, delays within the Department of Defense’s care system, and the need for better communication, coordination, and tracking of patient outcomes.

International Patent WO2020060606A1 describes “Cryptocurrency System Using Body Activity Data” describes a system where human biological signals, such as brain waves, body heat, pulse rate, and other measurable physiological activity are used as verification for cryptocurrency transactions and mining processes. The technology proposes collecting body-generated data through sensors, converting those signals into digital outputs, and using them as proof-of-work within a blockchain or centralized crypto system. This patent outlines a model where a person’s involuntary biological responses become part of a digital currency infrastructure, raising significant implications for privacy, autonomy, and the future integration of human activity with digital financial systems.

This declassified CIA document reveals that Ukrainian scientists were developing a device capable of remotely detecting and analyzing the human biofield—decades before today’s discussions about directed energy, neurological effects, and Havana Syndrome. Conducted inside a formal research institute and monitored by intelligence agencies, the project attempted to measure human bioenergetic signatures using technical instrumentation rather than theory. This file raises critical questions about how long such technologies have been studied, how far they may have advanced, and why these efforts remain largely unknown to the public.

US Patent 20180008145 A1 describes a dual EEG system capable of monitoring brain activity through both non-contact sensing and a personal EEG device at the same time. The technology enables simultaneous brain-wave tracking and communication between the two components, allowing continuous neural monitoring without requiring traditional physical electrode contact.

US Patent 20200279585 A1 outlines a system and method designed to detect COVID-19 using diagnostic techniques based on biological samples and viral markers. The patent details how the testing process identifies the presence of SARS-CoV-2 and establishes protocols for accurate detection. It represents one of the official filings documenting early technological approaches to COVID-19 testing during the pandemic.

US Patent 3951134 describes an apparatus and method for remotely monitoring and altering human brain waves. Filed decades ago, it details technology capable of influencing neurological activity from a distance using electromagnetic signals. This patent is significant because it shows that the concept of remotely affecting cognitive states and behaviors has been formally documented in government-sanctioned research, long before these capabilities were publicly acknowledged or discussed.US Patent 3951134 describes an apparatus and method for remotely monitoring and altering human brain waves. Filed decades ago, it details technology capable of influencing neurological activity from a distance using electromagnetic signals. This patent is significant because it shows that the concept of remotely affecting cognitive states and behaviors has been formally documented in government-sanctioned research, long before these capabilities were publicly acknowledged or discussed.